The YY-founded live game streaming platform raised $462m from Tencent last month at a valuation of $1.16bn.

The age-related disease drug developer, which counts Mayo Clinic and WuXi PharmaTech as investors, raised $55m as recently as last month.

Samsung-backed nLight Photonics has filed for an initial public offering, aiming to raise approximately $86.3m when it floats on the Nasdaq Global Market.

Aptus Therapeutics-backed Alzheon has set its pricing range at $13 to $15 and could raise almost $86.3m if underwriters take up their option to purchase additional shares.

Unum Therapeutics has listed on the Nasdaq Global Select Market, providing exits to Novo, Sanofi, EMS and Seattle Genetics.

Novartis-backed Homology Medicines priced its shares at $16 and raised $165m when it floated on the Nasdaq Global Select Market.

The digital signature technology provider, backed by Dell, Intel, Salesforce, Telstra, Visa, Deutsche Telekom, Samsung, NTT, Mitsui, BBVA, Alphabet and Comcast, has filed for a $100m IPO.

The online entertainment platform, which counts Tencent and Legend Capital among its investors, priced its initial public offering in the middle of its range.

The online video streaming platform, which is majority owned by Baidu, has priced its shares in the middle of its range and will have a $14.5bn market cap.

Tencent, Kunlun, Duomi and Shunya-backed video broadcasting app Inke has filed to go public after raising some $65m in funding.